A study for a 55 year old woman who takes Pepcid (an AI-powered real world drug study)

Summary:

13,018 females aged 55 (±5) who take the same drug and have adverse effects are studied. This is a phase IV clinical study for a 55 year old female patient who has Inflammatory Pain. The study is created by eHealthMe based on reports from sources including the FDA.

On Aug, 06, 2026

13,018 females aged 55 (±5) who take Pepcid and have adverse effects are studied.

Number of reports submitted per year:

Information of the patient in this study:

Age: 55
Gender: female

What are the drugs?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.

What are the conditions?

Inflammatory pain is found to be associated with 94 drugs and 172 conditions by eHealthMe. Check the latest studies of Inflammatory pain.

Common side effects *:

Chronic Kidney Disease : 1,370 people, 10.52%
Nausea (feeling of having an urge to vomit): 1,181 people, 9.07%
Fatigue (feeling of tiredness): 1,005 people, 7.72%
Acute Kidney Failure : 993 people, 7.63%
Pain : 848 people, 6.51%
Diarrhea : 826 people, 6.35%
Headache (pain in head): 798 people, 6.13%
Dyspnea (difficult or laboured breathing): 778 people, 5.98%
Nausea And Vomiting : 752 people, 5.78%
Fever : 693 people, 5.32%
Weakness : 676 people, 5.19%
Dizziness : 628 people, 4.82%
Rashes (redness): 609 people, 4.68%
Chest Pain : 600 people, 4.61%
Joint Pain : 591 people, 4.54%
Stress And Anxiety : 581 people, 4.46%
High Blood Pressure : 563 people, 4.32%
Drug Ineffective : 527 people, 4.05%
Fall : 495 people, 3.80%
Depression : 485 people, 3.73%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

Pain : 1,485 people, 11.41%
High Blood Pressure : 1,375 people, 10.56%
High Blood Cholesterol : 918 people, 7.05%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 863 people, 6.63%
Depression : 808 people, 6.21%
Stress And Anxiety : 726 people, 5.58%
Nausea (feeling of having an urge to vomit): 542 people, 4.16%
Diabetes : 510 people, 3.92%
Asthma : 457 people, 3.51%
Infection : 431 people, 3.31%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 430 people, 3.30%
Insomnia (sleeplessness): 421 people, 3.23%
Multiple Myeloma (cancer of the plasma cells): 407 people, 3.13%
Constipation : 377 people, 2.90%
Breast Cancer : 345 people, 2.65%
Hypersensitivity : 340 people, 2.61%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 338 people, 2.60%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 273 people, 2.10%
Osteoporosis (bones weak and more likely to break): 272 people, 2.09%
Migraine (headache): 258 people, 1.98%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

Drug effectiveness *:

Pepcid:

not at all: 1.9 %
somewhat: 20.48 %
moderate: 32.38 %
high: 31.9 %
very high: 13.33 %

* Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Pepcid: 55,774 reports

Treatments, associated medications and conditions:

Inflammatory pain: 1,685 reports

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.